Plain-English translation of NCT07228026 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →This trial is testing a new device called fenoTRACK that measures a substance in your breath called nitric oxide, which indicates inflammation in your airways. Researchers want to see if this device works accurately both at home and in a clinic setting, and whether the measurements it provides can help doctors track how well asthma treatments are working.
Currently, measuring airway inflammation requires special equipment that's usually only available in clinics. This trial exists to determine whether a portable home-use device could give patients and doctors a simple, convenient way to monitor asthma control and catch problems early.
You likely qualify if…
You likely don't qualify if…
If you join the uncontrolled asthma group, you'll have two visits about 2 weeks apart. At the first visit, you'll use the fenoTRACK device to measure your airway inflammation, complete breathing tests, answer questions about your asthma symptoms, and then start taking corticosteroid medication. At the second visit, you'll repeat these same measurements to see how the treatment improved your asthma. If you're in the controlled asthma group, you'll have similar visits but without starting new medication — the study is mainly checking that the device gives consistent, accurate measurements.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States